Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection

详细信息    查看全文

• 作者：Sarah E. Gill ; M.D.^a ; Michaela E. McGree ; B.S.^b ; Amy L. Weaver ; M.S.^b ; William A. Cliby ; M.D.^a ; Carrie L. Langstraat ; M.D.^a ; ^{langstraat.carrie@mayo.edu}
• 关键词：Neoadjuvant chemotherapy ; Interval debulking surgery ; Ovarian cancer ; Unresectable
• 刊名：Gynecologic Oncology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：144
• 期：2
• 页码：266-273
• 全文大小：464 K
• 卷排序：144

文摘

NACT/IDS is associated with improved survival in select patients. Patients treated with NACT/IDS have reduced perioperative morbidity. Younger age and normalization of CA-125 prior to IDS may improve survival.